RNF43 and nonpapillary renal cell carcinoma: Under pazopanib treatment, RNF43-overexpressing 786-O or 769-P cells showed inhibited proliferation and increased apoptosis compared with the control cells, suggesting that ccRCC cells with RNF43 overexpression were sensitive to the targeted drug (Figs. 3d and 3e; Suppl.